0001140361-15-029147.txt : 20150730 0001140361-15-029147.hdr.sgml : 20150730 20150730161953 ACCESSION NUMBER: 0001140361-15-029147 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150728 FILED AS OF DATE: 20150730 DATE AS OF CHANGE: 20150730 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Loxo Oncology, Inc. CENTRAL INDEX KEY: 0001581720 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462996673 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 LANDMARK SQUARE, SUITE 1122 CITY: STAMFORD STATE: CT ZIP: 06901 BUSINESS PHONE: 203-653-3880 MAIL ADDRESS: STREET 1: 1 LANDMARK SQUARE, SUITE 1122 CITY: STAMFORD STATE: CT ZIP: 06901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kunkel Lori Anne CENTRAL INDEX KEY: 0001536368 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36562 FILM NUMBER: 151016421 MAIL ADDRESS: STREET 1: C/O PHARMACYCLICS, INC. STREET 2: 995 EAST ARQUES AVENUE CITY: SUNNYVALE STATE: CA ZIP: 94085 4 1 doc1.xml FORM 4 X0306 4 2015-07-28 0 0001581720 Loxo Oncology, Inc. LOXO 0001536368 Kunkel Lori Anne C/O LOXO ONCOLOGY, INC. ONE LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901 1 0 0 0 Director Stock Option (right to buy) 20.91 2015-07-28 4 A 0 7812 0 A 2025-07-27 Common Stock 7812 7812 D The stock option vests and becomes exercisable in 12 equal monthly installments beginning one month after the grant date, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. /s/ Sara Slifka, by power of attorney 2015-07-30